XNASFONR
Market cap95mUSD
Jan 16, Last price
15.28USD
1D
0.39%
1Q
-2.61%
Jan 2017
-20.21%
Name
Fonar Corp
Chart & Performance
Profile
FONAR Corporation, together with its subsidiaries, engages in the research, development, production, and marketing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases in the United States. The company operates through two segments, Medical Equipment segment, and Physician Management and Diagnostic services segment. It provides Upright MRI scanner that allows patients to be scanned in weight-bearing conditions, such as standing, sitting, bending, or lying down. The company offers non-medical management, including administrative services, billing and collection services, credentialing services, contract negotiations, compliance consulting, purchasing IT services, hiring, conducting interviews, training, supervision and management of non-medical personnel, storage of medical records, office space, equipment, repair maintenance services, accounting, assistance with compliance matters and the development and implementation of practice growth and marketing strategies. The company owns and operates 5 diagnostic imaging facilities in Florida; and manages 39 MRI scanning facilities, including 25 facilities located in New York and 14 situated in Florida. It markets its scanners to private diagnostic imaging centers and hospitals. The company was incorporated in 1978 and is based in Melville, New York.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|---|
2024‑06 | 2023‑06 | 2022‑06 | 2021‑06 | 2020‑06 | 2019‑06 | 2018‑06 | 2017‑06 | 2016‑06 | 2015‑06 | |
Income | ||||||||||
Revenues | 102,884 4.30% | 98,645 1.08% | 97,592 8.52% | |||||||
Cost of revenue | 59,480 | 54,465 | 52,072 | |||||||
Unusual Expense (Income) | ||||||||||
NOPBT | 43,404 | 44,180 | 45,520 | |||||||
NOPBT Margin | 42.19% | 44.79% | 46.64% | |||||||
Operating Taxes | 5,169 | 3,632 | 5,534 | |||||||
Tax Rate | 11.91% | 8.22% | 12.16% | |||||||
NOPAT | 38,235 | 40,548 | 39,985 | |||||||
Net income | 10,567 12.71% | 9,376 -45.60% | 17,234 26.04% | |||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | (2,506) | (1,759) | ||||||||
BB yield | 2.42% | 1.52% | ||||||||
Debt | ||||||||||
Debt current | 3,746 | 8,290 | 4,130 | |||||||
Long-term debt | 79,491 | 69,690 | 72,104 | |||||||
Deferred revenue | 1,175 | 760 | 1,857 | |||||||
Other long-term liabilities | 125 | 134 | 199 | |||||||
Net debt | 26,761 | 25,957 | 25,607 | |||||||
Cash flow | ||||||||||
Cash from operating activities | 14,093 | 14,467 | 15,301 | |||||||
CAPEX | (790) | (4,338) | (4,633) | |||||||
Cash from investing activities | (851) | (4,338) | (5,179) | |||||||
Cash from financing activities | (8,181) | (7,572) | (5,859) | |||||||
FCF | 27,938 | 36,537 | 26,292 | |||||||
Balance | ||||||||||
Cash | 56,477 | 51,313 | 48,755 | |||||||
Long term investments | 710 | 1,872 | ||||||||
Excess cash | 51,333 | 47,090 | 45,748 | |||||||
Stockholders' equity | (22,802) | (31,270) | (37,620) | |||||||
Invested Capital | 222,566 | 219,688 | 223,497 | |||||||
ROIC | 17.29% | 18.30% | 18.00% | |||||||
ROCE | 21.69% | 23.40% | 24.46% | |||||||
EV | ||||||||||
Common stock shares outstanding | 6,478 | 6,773 | 6,788 | |||||||
Price | 16.00 -6.43% | 17.10 12.57% | 15.19 -14.08% | |||||||
Market cap | 103,654 -10.50% | 115,821 12.33% | 103,109 -13.46% | |||||||
EV | 121,235 | 134,699 | 124,663 | |||||||
EBITDA | 52,312 | 52,985 | 54,055 | |||||||
EV/EBITDA | 2.32 | 2.54 | 2.31 | |||||||
Interest | 77 | 50 | 347 | |||||||
Interest/NOPBT | 0.18% | 0.11% | 0.76% |